0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Ischemic Stroke Market Research Report 2023
Published Date: May 2023
|
Report Code: QYRE-Auto-30J7671
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Acute Ischemic Stroke Market Insights and Forecast to 2028
BUY CHAPTERS

Global Acute Ischemic Stroke Market Research Report 2023

Code: QYRE-Auto-30J7671
Report
May 2023
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Acute Ischemic Stroke Market

The global Acute Ischemic Stroke market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Acute Ischemic Stroke is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Acute Ischemic Stroke is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Acute Ischemic Stroke in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Acute Ischemic Stroke include Bayer, Boehringer Ingelheim, Roche, Sanofi, Biogen, Daiichi Sankyo and Pfizer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acute Ischemic Stroke, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Ischemic Stroke.
The Acute Ischemic Stroke market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acute Ischemic Stroke market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Ischemic Stroke companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Acute Ischemic Stroke Market Report

Report Metric Details
Report Name Acute Ischemic Stroke Market
Segment by Type
  • Antihypertensive Therapeutics
  • Antiplatelet Therapeutics
  • Anticoagulants
Segment by Application
  • Hospitals
  • Ambulatory Surgical Center
  • Diagnostic Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Boehringer Ingelheim, Roche, Sanofi, Biogen, Daiichi Sankyo, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Acute Ischemic Stroke companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antihypertensive Therapeutics
1.2.3 Antiplatelet Therapeutics
1.2.4 Anticoagulants
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Market Perspective (2018-2029)
2.2 Acute Ischemic Stroke Growth Trends by Region
2.2.1 Global Acute Ischemic Stroke Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Ischemic Stroke Historic Market Size by Region (2018-2023)
2.2.3 Acute Ischemic Stroke Forecasted Market Size by Region (2024-2029)
2.3 Acute Ischemic Stroke Market Dynamics
2.3.1 Acute Ischemic Stroke Industry Trends
2.3.2 Acute Ischemic Stroke Market Drivers
2.3.3 Acute Ischemic Stroke Market Challenges
2.3.4 Acute Ischemic Stroke Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Players by Revenue (2018-2023)
3.1.2 Global Acute Ischemic Stroke Revenue Market Share by Players (2018-2023)
3.2 Global Acute Ischemic Stroke Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Revenue
3.4 Global Acute Ischemic Stroke Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Revenue in 2022
3.5 Acute Ischemic Stroke Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Ischemic Stroke Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Historic Market Size by Type (2018-2023)
4.2 Global Acute Ischemic Stroke Forecasted Market Size by Type (2024-2029)
5 Acute Ischemic Stroke Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Historic Market Size by Application (2018-2023)
5.2 Global Acute Ischemic Stroke Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Ischemic Stroke Market Size (2018-2029)
6.2 North America Acute Ischemic Stroke Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acute Ischemic Stroke Market Size by Country (2018-2023)
6.4 North America Acute Ischemic Stroke Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Ischemic Stroke Market Size (2018-2029)
7.2 Europe Acute Ischemic Stroke Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acute Ischemic Stroke Market Size by Country (2018-2023)
7.4 Europe Acute Ischemic Stroke Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Market Size (2018-2029)
8.2 Asia-Pacific Acute Ischemic Stroke Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acute Ischemic Stroke Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Ischemic Stroke Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Ischemic Stroke Market Size (2018-2029)
9.2 Latin America Acute Ischemic Stroke Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acute Ischemic Stroke Market Size by Country (2018-2023)
9.4 Latin America Acute Ischemic Stroke Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Market Size (2018-2029)
10.2 Middle East & Africa Acute Ischemic Stroke Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acute Ischemic Stroke Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Ischemic Stroke Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Acute Ischemic Stroke Introduction
11.1.4 Bayer Revenue in Acute Ischemic Stroke Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Acute Ischemic Stroke Introduction
11.2.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Acute Ischemic Stroke Introduction
11.3.4 Roche Revenue in Acute Ischemic Stroke Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Acute Ischemic Stroke Introduction
11.4.4 Sanofi Revenue in Acute Ischemic Stroke Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Acute Ischemic Stroke Introduction
11.5.4 Biogen Revenue in Acute Ischemic Stroke Business (2018-2023)
11.5.5 Biogen Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Detail
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Acute Ischemic Stroke Introduction
11.6.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Business (2018-2023)
11.6.5 Daiichi Sankyo Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Acute Ischemic Stroke Introduction
11.7.4 Pfizer Revenue in Acute Ischemic Stroke Business (2018-2023)
11.7.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Acute Ischemic Stroke Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Antihypertensive Therapeutics
    Table 3. Key Players of Antiplatelet Therapeutics
    Table 4. Key Players of Anticoagulants
    Table 5. Global Acute Ischemic Stroke Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Acute Ischemic Stroke Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Acute Ischemic Stroke Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Acute Ischemic Stroke Market Share by Region (2018-2023)
    Table 9. Global Acute Ischemic Stroke Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Acute Ischemic Stroke Market Share by Region (2024-2029)
    Table 11. Acute Ischemic Stroke Market Trends
    Table 12. Acute Ischemic Stroke Market Drivers
    Table 13. Acute Ischemic Stroke Market Challenges
    Table 14. Acute Ischemic Stroke Market Restraints
    Table 15. Global Acute Ischemic Stroke Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Acute Ischemic Stroke Market Share by Players (2018-2023)
    Table 17. Global Top Acute Ischemic Stroke Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke as of 2022)
    Table 18. Ranking of Global Top Acute Ischemic Stroke Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Acute Ischemic Stroke Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Acute Ischemic Stroke Product Solution and Service
    Table 22. Date of Enter into Acute Ischemic Stroke Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Acute Ischemic Stroke Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Acute Ischemic Stroke Revenue Market Share by Type (2018-2023)
    Table 26. Global Acute Ischemic Stroke Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Acute Ischemic Stroke Revenue Market Share by Type (2024-2029)
    Table 28. Global Acute Ischemic Stroke Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Acute Ischemic Stroke Revenue Market Share by Application (2018-2023)
    Table 30. Global Acute Ischemic Stroke Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Acute Ischemic Stroke Revenue Market Share by Application (2024-2029)
    Table 32. North America Acute Ischemic Stroke Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Acute Ischemic Stroke Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Acute Ischemic Stroke Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Acute Ischemic Stroke Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Acute Ischemic Stroke Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Acute Ischemic Stroke Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Acute Ischemic Stroke Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Acute Ischemic Stroke Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Acute Ischemic Stroke Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Acute Ischemic Stroke Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Acute Ischemic Stroke Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Acute Ischemic Stroke Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Acute Ischemic Stroke Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Acute Ischemic Stroke Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Acute Ischemic Stroke Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Bayer Company Detail
    Table 48. Bayer Business Overview
    Table 49. Bayer Acute Ischemic Stroke Product
    Table 50. Bayer Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 51. Bayer Recent Development
    Table 52. Boehringer Ingelheim Company Detail
    Table 53. Boehringer Ingelheim Business Overview
    Table 54. Boehringer Ingelheim Acute Ischemic Stroke Product
    Table 55. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 56. Boehringer Ingelheim Recent Development
    Table 57. Roche Company Detail
    Table 58. Roche Business Overview
    Table 59. Roche Acute Ischemic Stroke Product
    Table 60. Roche Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 61. Roche Recent Development
    Table 62. Sanofi Company Detail
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Acute Ischemic Stroke Product
    Table 65. Sanofi Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 66. Sanofi Recent Development
    Table 67. Biogen Company Detail
    Table 68. Biogen Business Overview
    Table 69. Biogen Acute Ischemic Stroke Product
    Table 70. Biogen Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 71. Biogen Recent Development
    Table 72. Daiichi Sankyo Company Detail
    Table 73. Daiichi Sankyo Business Overview
    Table 74. Daiichi Sankyo Acute Ischemic Stroke Product
    Table 75. Daiichi Sankyo Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 76. Daiichi Sankyo Recent Development
    Table 77. Pfizer Company Detail
    Table 78. Pfizer Business Overview
    Table 79. Pfizer Acute Ischemic Stroke Product
    Table 80. Pfizer Revenue in Acute Ischemic Stroke Business (2018-2023) & (US$ Million)
    Table 81. Pfizer Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Ischemic Stroke Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Acute Ischemic Stroke Market Share by Type: 2022 VS 2029
    Figure 3. Antihypertensive Therapeutics Features
    Figure 4. Antiplatelet Therapeutics Features
    Figure 5. Anticoagulants Features
    Figure 6. Global Acute Ischemic Stroke Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Acute Ischemic Stroke Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Center Case Studies
    Figure 10. Diagnostic Centers Case Studies
    Figure 11. Acute Ischemic Stroke Report Years Considered
    Figure 12. Global Acute Ischemic Stroke Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Acute Ischemic Stroke Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Acute Ischemic Stroke Market Share by Region: 2022 VS 2029
    Figure 15. Global Acute Ischemic Stroke Market Share by Players in 2022
    Figure 16. Global Top Acute Ischemic Stroke Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Ischemic Stroke as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Revenue in 2022
    Figure 18. North America Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Acute Ischemic Stroke Market Share by Country (2018-2029)
    Figure 20. United States Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Acute Ischemic Stroke Market Share by Country (2018-2029)
    Figure 24. Germany Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Acute Ischemic Stroke Market Share by Region (2018-2029)
    Figure 32. China Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Acute Ischemic Stroke Market Share by Country (2018-2029)
    Figure 40. Mexico Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Acute Ischemic Stroke Market Share by Country (2018-2029)
    Figure 44. Turkey Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Acute Ischemic Stroke Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Bayer Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 47. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 48. Roche Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 49. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 50. Biogen Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 51. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 52. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Artery Imaging Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37R6046
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global ECG Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23S9116
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Decentralized & POC Coagulation Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7S6333
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Aortic Valve Implantation (TAVI) System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37M13084
Sun Apr 07 00:00:00 UTC 2024

Add to Cart